// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Defining the Ideal Distal "Exit Point" of a Tibial Intramedullary Nail: A CT Analysis of 860 Tibiae

Alex Trompeter - Orthopaedic Trauma Association (OTA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcomes of Isolated Ulnar Diaphyseal Fractures

William M. Oliver - Orthopaedic Trauma Association (OTA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

N/A

Is the Pit-Stop Trauma Transfer Hazardous to Health? An Analysis of 10,870 Patients Over 20 Years of Trauma Care

Ben A. Marson - Orthopaedic Trauma Association (OTA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

N/A

Should We Remove Clavicle Plates to Prevent Periprosthetic Fractures?

Ben A. Marson - Orthopaedic Trauma Association (OTA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

N/A

Machine Learning Has a Higher Accuracy Than Clinicians in Classifying Hip Fractures

Tim Chesser - Orthopaedic Trauma Association (OTA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does Payment by Performance Reduce Mortality After Sustaining a Hip Fracture?

Haseeb Khawar - Orthopaedic Trauma Association (OTA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Advanced Data-Driven Analysis Methods for Successful Mapping of Brain-Symptom Associations From Heterogeneous Datasets

Janine Bijsterbosch - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pavlovian Biases in Depression: From Choice to Thought and Therapy

Quentin Huys - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Neurocognitive Predictors of Depression Relapse

Quentin Huys - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Mental Imagery as an Emotional Amplifier in Bipolar Disorder

Martina Di Simplicio - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Bipolar disorder

N/A

Low Decision Acuity, a General Factor for Decision-Making Underpinned by Specific Resting-State Brain Activity, is Associated With High Aberrant Thinking in Young People

Michael Moutoussis - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Epigenome-Wide Association Study and Multi-Tissue Replication of Individuals With Alcohol Use Disorder: Evidence for Abnormal Glucocorticoid Signaling Pathway Gene Regulation

Falk Lohoff - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

Substance Abuse

Alcohol Dependence

Glucocorticoid

Reversal Learning in Obsessive Compulsive Disorder: Uncertainty, Punishment, Serotonin and Perseveration

Annemieke Apergis-Schoute - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Obsessive compulsive disorder

N/A

Effects of Task-Irrelevant Arousal on State Transition Learning

Paul Sharp - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Anxiety

N/A

Ketamine Can Reduce Harmful Drinking by Pharmacologically Rewriting Drinking Memories

Ravi Das - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ketamine Injection

Low Predictive Power of Clinical Features for Relapse Prediction After Antidepressant Discontinuation in a Naturalistic Setting

Isabel M. Berwian - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Measuring and Estimating the Effect Size of Rare Non-Recurrent Deletions and Duplications on General Intelligence

Guillaume Huguet - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Reward-Related Brain Function in Lifetime Depression, Anxiety, and Comorbid Depression and Anxiety

Zachary Anderson - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Teenagers, Compared to Adults, are More Vulnerable to the Psychotic-Like and Addiction-Forming Risks Associated With Chronic Cannabis Use

Will Lawn - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Assessing Threat of Shock-Induced Anxiety as an Intermediate Translational Model of Anxiety Disorders: An fMRI Meta-Analysis

Alice Chavanne - Society of Biological Psychiatry (SOBP) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Anxiety

N/A

Copyright © 2026. QuantiNova All rights reserved